CD14 and Cirrhosis: AXL+ monocytes showed preserved phagocytosis capacities for E. coli bioparticles and live E. coli bacteria, whereas M-MDSCs revealed reduced phagocytosis, when compared with CD14+HLA-DR+AXL− monocytes from patients with cirrhosis and HC (Figs 4D and S7C).